Delivery Order SPE2DB20D1004-SPE2DB25FNKDR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,759.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes valued at $1,379.80 with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance scheduled for completion by July 25, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used by the Department of Defense for military personnel and beneficiaries requiring...
- The Defense Logistics Agency awarded a delivery order valued at $1,034.85 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is not set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product, reflecting the federal government's ongoing need to maintain medical supply inventories for...
- The Defense Logistics Agency awarded a delivery order valued at $5,174.25 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement of a specific pharmaceutical product to be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine indicated for immunization against typhoid fever,...
- The Defense Logistics Agency awarded a $20,697 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccination product, reflecting the federal government's pharmaceutical supply requirements for military...
- The Defense Logistics Agency awarded a delivery order valued at $6,899 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price contract with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization purposes across military and federal...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,697.07 on August 12, 2025, for TYPHIM VI 25 MCG/0.5 ML vials (10 mL units). This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for...
- The Defense Logistics Agency awarded a $6,899.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with a completion date of August 4, 2025. This delivery order, which was not set aside for any specific business category, was issued on August 1, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid conjugate vaccine used for immunization purposes, representing part of the broad...
- The Defense Logistics Agency awarded a delivery order valued at $11,383.35 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine product supplied through standard federal pharmaceutical procurement channels to support military and...
- The Defense Logistics Agency awarded a $6,899.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The work...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKDRDelivery Order
The Defense Logistics Agency awarded a $44,212.72 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitive award, which has no set-aside designation, is scheduled for completion by August 18, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization purposes, representing part of the federal government's pharmaceutical and vaccine procurement requirements for military and healthcare system support. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying an extensive range of medications, vaccines, and medical devices to support military healthcare programs and other government healthcare systems. The company's significant IDC vehicle enables flexible fulfillment of diverse pharmaceutical requirements across multiple therapeutic domains on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.2k | 8/15/25 |